[
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "This capacity was recently recognized by the newly established African Centers of Disease Control which has designated Kenya as a regional collaborating center, to support disease prevention and outbreak response throughout the region.Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "The full contents of the supplement are available online at https://bmcpublichealth.biomedcentral.com/articles/supplements/volume-19-supplement-3.Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.Development of new diagnostic technology to detect emerging and re-emerging pathogens\nThe diagnostic capacity in DLSP laboratories has been augmenting annually since 2004.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Overview of DSLP laboratories\nDLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "DLSP current activities take place in three KEMRI laboratories, one in Kisumu and two in Nairobi (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "Arrows represent implementation of Polymerase Chain Reaction (PCR) and TaqMan Array Card (TAC)Fig. 3.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "In Kenya, DGHP has supported investigations into outbreaks of respiratory diseases (e.g., influenza, pertussis), diarrheal diseases (e.g., cholera, Salmonella Typhi, shigellosis), aflatoxicosis, and vector-borne diseases (e.g., Zika, dengue, chikungunya, Rift Valley fever viruses) (Fig. 3) [9, 22–27].",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 3",
        "panel": "",
        "figure_key": "figure_3"
      }
    ]
  },
  {
    "sentence": "The complete number of outbreaks and training performed in the region is summarized in Fig. 4.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "To date DLSP, across its three participating laboratories, is capable of testing for 153 different pathogens by rRT-PCR, serological assays, microscopy, bacterial and viral culture, immunofluorescence and TAC. (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Within 3 years, the project will expand to include an additional 8 counties with improved capacity in microbiology techniques, AMR, specimen referral and shipping (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "As of 2016, NPHLS NIC has successfully assumed diagnostic testing responsibility for 2 of the 5 influenza sentinel surveillance sites in the country (Fig. 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Over the last decade DLSP trained technical staff from Kenya and neighboring countries in PCR, ELISA and microbiology diagnostic techniques to detect multiple pathogens (Fig. 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Acknowledgements\nSpecial thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Special thanks to Radha Friedman for providing Fig. 4 of this article.",
    "figure_references": [
      {
        "figure_number": "Figure 4",
        "panel": "",
        "figure_key": "figure_4"
      }
    ]
  },
  {
    "sentence": "Authors’ contributions\nEH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "EH created the content, wrote the manuscript and created Fig. 3a, BJ contributed the biosafety/biosecurity section and microbiology AMR, CO contributed to TAC and Fig. 2, JBO contributed to the enteric studies, VO contributed to the one health projects, BSF contributed in outbreak response, TAC and pathogen discovery, MKN was the first lab director of DLSP, JM contributed to the HIV/TB information, GB is the branch chief of CGHR and oversaw the projects listed in this manuscript, RO contributed to RVIDA project, NO contributed to the flu program in western Kenya, SSC is the director of the CDC Kenya flu program and contributed to the flu information, PM contributed to the one health information, DMN contributed in lab mapping and Fig. 1, JV contributed on the PBIDS platform, SL contributed in the FELTP information, RFB developed the PBIDS platform, JM contributed to all the surveillance platforms, KDC is the country director and contributed in editing and content of manuscript and MAW is the DGHP director who contributed in writing, editing and the content of the manuscript.",
    "figure_references": [
      {
        "figure_number": "Figure 3",
        "panel": "Panel a",
        "figure_key": "figure_3"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  }
]